148 related articles for article (PubMed ID: 7787431)
1. Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro.
Hoelting T; Tezelman S; Siperstein AE; Duh QY; Clark OH
Thyroid; 1995 Feb; 5(1):35-40. PubMed ID: 7787431
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines.
Hölting T; Zielke A; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Sep; 79(3):806-13. PubMed ID: 8077365
[TBL] [Abstract][Full Text] [Related]
3. Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro.
Hoelting T; Zielke A; Siperstein AE; Clark OH; Duh QY
Clin Exp Metastasis; 1994 Jul; 12(4):315-23. PubMed ID: 8039305
[TBL] [Abstract][Full Text] [Related]
4. [Growth and invasion in differentiated thyroid carcinoma. Function of different growth factors].
Hölting T; Duh OY; Clark OH; Herfarth C
Chirurg; 1994 Dec; 65(12):1100-6. PubMed ID: 7851142
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
Hoelting T; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen inhibits growth, migration, and invasion of human follicular and papillary thyroid cancer cells in vitro and in vivo.
Hoelting T; Siperstein AE; Duh QY; Clark OH
J Clin Endocrinol Metab; 1995 Jan; 80(1):308-13. PubMed ID: 7829632
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analog octreotide inhibits the growth of differentiated thyroid cancer cells in vitro, but not in vivo.
Hoelting T; Duh QY; Clark OH; Herfarth C
J Clin Endocrinol Metab; 1996 Jul; 81(7):2638-41. PubMed ID: 8675590
[TBL] [Abstract][Full Text] [Related]
8. Expression and secretion of endostatin in thyroid cancer.
Hoffmann S; Wunderlich A; Lingelbach S; Musholt PB; Musholt TJ; von Wasielewski R; Zielke A
Ann Surg Oncol; 2008 Dec; 15(12):3601-8. PubMed ID: 18818971
[TBL] [Abstract][Full Text] [Related]
9. [Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].
Hoelting T; Duh QY; Clark OH; Herfarth C
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):281-4. PubMed ID: 14518260
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effects of thyroid stimulating hormone in a differentiated thyroid cancer cell line. Studies on proliferation, thyroglobulin secretion, adhesion, migration and invasion.
Zielke A; Hoffmann S; Plaul U; Duh QY; Clark OH; Rothmund M
Exp Clin Endocrinol Diabetes; 1999; 107(6):361-9. PubMed ID: 10543413
[TBL] [Abstract][Full Text] [Related]
11. [Growth and invasion of differentiated thyroid gland carcinoma: importance of signal transduction].
Hölting T; Duh OY; Clark OH; Herfarth C
Langenbecks Arch Chir; 1995; 380(2):96-101. PubMed ID: 7760657
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
Machens A; Holzhausen HJ; Dralle H
Cancer; 2005 Jun; 103(11):2269-73. PubMed ID: 15856429
[TBL] [Abstract][Full Text] [Related]
13. Significance of tumor capsular invasion in well-differentiated thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
Am Surg; 2007 May; 73(5):484-91. PubMed ID: 17521005
[TBL] [Abstract][Full Text] [Related]
14. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
Tuttle RM; Fleisher M; Francis GL; Robbins RJ
J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
[TBL] [Abstract][Full Text] [Related]
15. Follicular thyroid cancer cells: a model of metastatic tumor in vitro (review).
Hoelting T; Goretzki PE; Duh QY
Oncol Rep; 2001; 8(1):3-8. PubMed ID: 11115561
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen antagonizes proliferation and invasion of estrogen receptor-negative metastatic follicular thyroid cancer cells via protein kinase C.
Hoelting T; Duh QY; Clark OH; Herfarth C
Cancer Lett; 1996 Feb; 100(1-2):89-93. PubMed ID: 8620458
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC- rather than PKA-activation.
Hoelting T; Tezelman S; Siperstein AE; Duh QY; Clark OH
Biochem Biophys Res Commun; 1993 Sep; 195(3):1230-6. PubMed ID: 8216254
[TBL] [Abstract][Full Text] [Related]
18. The heat shock protein 90-binding geldanamycin inhibits cancer cell proliferation, down-regulates oncoproteins, and inhibits epidermal growth factor-induced invasion in thyroid cancer cell lines.
Park JW; Yeh MW; Wong MG; Lobo M; Hyun WC; Duh QY; Clark OH
J Clin Endocrinol Metab; 2003 Jul; 88(7):3346-53. PubMed ID: 12843186
[TBL] [Abstract][Full Text] [Related]
19. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
Cooper DS; Specker B; Ho M; Sperling M; Ladenson PW; Ross DS; Ain KB; Bigos ST; Brierley JD; Haugen BR; Klein I; Robbins J; Sherman SI; Taylor T; Maxon HR
Thyroid; 1998 Sep; 8(9):737-44. PubMed ID: 9777742
[TBL] [Abstract][Full Text] [Related]
20. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
